EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.
ECILC
Rank in Stocks
#10381
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a... EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a Turkish enterprise, operating predominantly in the health and real estate development sectors through its various subsidiaries. Its Health division is responsible for the production and distribution of pharmaceutical goods for both human and veterinary applications. Concurrently, the Real Estate Development segment is engaged in property creation and offers consultancy pertaining to land development and project oversight. This company, established in Istanbul, Turkey, in 1951, functions as a subsidiary of Eczacibasi Holding A.S.
Share Price
$1.03
Last synced: 2026-11-09
Market Cap
$702.77M
Change (1 day)
4.27%
Change (1 year)
-47.68%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (ECILC)
Category
Healthcare
Operating Margin for EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (ECILC)
Operating Margin as of November 2026 TTM: -2.52%
According to EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s latest financial reports, its current operating margin (TTM) is -2.52%. At the end of 2025 the company had an operating margin of -4.30%.
Operating Margin history for EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -2.52% | -41.40% |
| 2025 | -4.30% | -197.07% |
| 2024 | 4.43% | -92.57% |
| 2023 | 59.66% | 58.97% |
| 2022 | 37.53% | -40.07% |
| 2021 | 62.62% | 91.56% |
| 2020 | 32.69% | 27.50% |
| 2019 | 25.64% | -14.85% |
| 2018 | 30.11% | 39.46% |
| 2017 | 21.59% | 96.81% |
| 2016 | 10.97% | 3.78% |
| 2015 | 10.57% | 497.18% |
| 2014 | 1.77% | -85.20% |
| 2013 | 11.96% | 483.41% |
| 2012 | 2.05% | 86.36% |
| 2011 | 1.10% | -80.18% |
| 2010 | 5.55% | 213.56% |
| 2009 | 1.77% | -502.27% |
| 2008 | -0.44% | -135.20% |
| 2007 | 1.25% | -81.32% |
| 2006 | 6.69% | 114.42% |
| 2005 | 3.12% | -58.01% |
| 2004 | 7.43% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -107.70% |
DE
|
|
| 19.68% | -107.81% |
DE
|
|
| 13.26% | -105.26% |
JP
|
|
| 17.08% | -106.78% |
CH
|
|
| 14.92% | -105.92% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s operating margin
What is EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s operating margin?
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s operating margin is -2.52%, as of Nov 2026.
What was EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s operating margin in 2025?
In 2025, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s operating margin was -4.30%, compared with 4.43% in 2024.
How has EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s operating margin changed since 2020?
From 2020 to 2025, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s operating margin was highest in 2021 (62.62%) and lowest in 2025 (-4.30%).
How does EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s operating margin compare with similar companies?
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s operating margin (-2.52%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.